zax.doi.bio/contact
Get in Touch
Join the Private Preview
We're working with select design partners to refine the doi.bio platform. If you're interested in transforming how your team discovers and develops new therapeutics, we'd love to hear from you.
Contact Information
sness@sness.net
For general inquiries, partnership opportunities, or demo requests.
Connect with our founder to discuss the platform, potential collaborations, or opportunities in structural biology and AI-driven drug discovery.
Platform
Visit our main platform to explore live surfaces and see the technology in action.
Live Platforms
Experience doi.bio's capabilities through our live demonstration surfaces:
c.doi.bio
Collaborative Multiuser Notebook
Real-time collaborative workspace for teams to capture experiments, rationales, and decisions. Think Google Docs meets Jupyter Notebook, purpose-built for molecular discovery.
ci.doi.bio
Collaborative Molecular Viewer
Synchronized 3D structure viewing with built-in PDB and AlphaFold integration. Teams can explore proteins together, annotate binding pockets, and share structural insights in real-time.
ai.doi.bio
AI Assistant for Molecules
Ask questions about your proteins and get AI-powered answers grounded in structural context. Query PDB metadata, get binding site predictions, or explore structure-function relationships through natural language.
Who Should Reach Out?
Pharmaceutical & Biotech Companies
- Drug discovery teams looking to accelerate target validation
- Structural biology groups managing AlphaFold predictions
- Computational chemistry teams needing better collaboration tools
Contract Research Organizations (CROs)
- CROs providing structure-based drug design services
- Organizations managing multiple client projects simultaneously
- Teams needing better knowledge capture and handoff workflows
Academic Research Labs
- Structural biology labs with collaborative projects
- Computational groups developing new molecular design methods
- Research teams looking to improve reproducibility and knowledge transfer
Investors & Advisors
- VCs interested in AI-enabled drug discovery platforms
- Industry experts who could advise on product-market fit
- Business development professionals for strategic partnerships
What to Expect
When you reach out, we'll:
- Initial Discussion - 30-minute call to understand your workflow and challenges
- Platform Demo - Hands-on walkthrough of relevant doi.bio capabilities
- Design Partnership - For select teams, opportunity to shape the platform's development
- Pilot Program - Private access with dedicated support and regular feedback sessions
Frequently Asked Questions
When will doi.bio be generally available?
We're currently in private preview with select design partners. General availability is planned for Q2 2025, with early access programs starting in Q1 2025.
What does it cost?
Pricing will be based on team size and usage. Academic research labs will have access to discounted rates. Contact us for details.
Can we integrate with our existing tools?
Yes! doi.bio is designed to complement your existing workflow. We provide APIs and integrations with common computational chemistry and structural biology tools.
Do you support on-premise deployment?
For enterprise customers with strict data governance requirements, we're developing on-premise and private cloud deployment options. Contact us to discuss your needs.
How is our data protected?
We take data security seriously. All data is encrypted in transit and at rest. We're working towards SOC 2 compliance and can accommodate specific security requirements.
Office Hours
Interested in a quick chat? Steven holds virtual office hours:
Every Wednesday, 2-4 PM Pacific
Book a 15-minute slot to ask questions, see a quick demo, or discuss collaboration opportunities.
doi.bio - Where papers meet proteins. Where teams move faster.